30 Years of Evidence
Join the experts’ corner
This page presents publications and webinars from around the globe. It includes evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and motion synchronization techniques for both the CyberKnife® and TomoTherapy® platforms. We update new papers on a regular basis. Please take a moment to explore the page and see the evidence we have collected to truly demonstrate how we are making a change to peoples’ lives.
Featured Content
ESTRO 2024
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Date: 2024
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Binnaz Yasar et al.
ESTRO 2024
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Date: 2024
Treatment Technique: IG-IMRT
Platform: TomoTherapy System
Author: Huang Wenhan et al.
ESTRO 2024
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Date: 2024
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Esmeralda Scipilliti et al.
CyberKnife® SBRT for Prostate Cancer: Is 5 better than 44?
Olusola Obayomi-Davies
Building a Prostate SBRT Program with the CyberKnife® System
Jonathan A. Haas
Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints
Meier RM, Bloch DA, Cotrutz C, Beckman AC, Henning GT, Woodhouse SA, Williamson SK, Mohideen N, Dombrowski JJ, Hong RL, Brachman DG, Linson PW, Kaplan ID. | Int J Radiat Oncol Biol Phys | 2018
Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial
Wang K, Chen RC, Kane B, Medbery CA, Underhill K, Gray JR, Peddada AV, Fuller DB | Int J Radiat Oncol Biol Phys | 2018
5-year Biochemical Outcomes of Stereotactic Body Radiotherapy with Intraprostatic Dose Escalation for Unfavorable Prostate Cancer
Blacksburg SR, Aghdam N, Royce TJ, Burri RJ, Obayomi-Davies O, Mezeckis M, Meier R, Fuller DB, Chen RC, Lanciano RM, Haas JA, Collins SP | Int J Radiat Oncol Biol Phys | 2019